IL6 and ovarian carcinoma: Excessive IL-6 production promotes tumorigenesis (in breast, prostate, lung, colon, ovarian cancer), in this respect, to prevent cancer progression, a pharmacological modulation of IL-6 gene expression levels may have therapeutic benefits in human.